|
2017 Journal Article Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemiaFleming, Shaun, Ong, Doen Ming, Jackson, Kathryn, Avery, Sharon, Mollee, Peter, Marlton, Paula, Kennedy, Glen and Wei, Andrew H (2017). Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia. British Journal of Haematology, 177 (2), 328-330. doi: 10.1111/bjh.14063 |
|
2017 Journal Article Malabsorption secondary to gout-induced amyloidosisAzzam, Ali, Balasubramaniam, Renuka, Safa, Shahram, McIvor, Carolyn and Mollee, Peter (2017). Malabsorption secondary to gout-induced amyloidosis. ACG Case Reports Journal, 4 (1), e32. doi: 10.14309/crj.2017.32 |
|
2017 Journal Article Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or r-chop consolidation in an international, prospective, multicenter Phase II trialTrappe, Ralf U., Dierickx, Daan, Zimmermann, Heiner, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M., Dreyling, Martin H., Duhrsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Huttmann, Andreas, Tousseyn, Thomas, Salles, Gilles, Kliem, Volker, Hauser, Ingeborg A., Tarella, Corrado, Neste, Eric Van Den, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno and Choquet, Sylvain (2017). Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or r-chop consolidation in an international, prospective, multicenter Phase II trial. Journal of Clinical Oncology, 35 (5), 536-543. doi: 10.1200/JCO.2016.69.3564 |
|
2017 Journal Article Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome : MGRS triggering aHUSMahmood, Usman, Isbel, Nicole, Mollee, Peter, Mallett, Andrew, Govindarajulu, Sridevi and Francis, Ross (2017). Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome : MGRS triggering aHUS. Nephrology, 22 (S1), 15-17. doi: 10.1111/nep.12934 |
|
2017 Journal Article Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupTalaulikar, Dipti, Tam, Constantine S., Joshua, Douglas, Ho, Joy Phoebe, Szer, Jeff, Quach, Hang, Spencer, Andrew, Harrison, Simon, Mollee, Peter, Roberts, Andrew W., Horvath, Noemi, Lee, Cindy, Zannettino, Andrew, Brown, Ross, Augustson, Bradley, Jaksic, Wilfrid, Gibson, John, Kalff, Anna, Johnston, Anna, Trotman, Judith, Kalro, Akash, Grigoriadis, George, Ward, Chris and Prince, H. Miles (2017). Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 47 (1), 35-49. doi: 10.1111/imj.13311 |
|
2016 Journal Article Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registryBergin, Krystal, Moore, Elizabeth, McQuilten, Zoe, Wood, Erica, Augustson, Bradley, Blacklock, Hilary, Ho, Joy, Horvath, Noemi, King, Tracy, McNeil, John, Mollee, Peter, Quach, Hang, Reid, Christopher M., Rosengarten, Brian, Walker, Patricia and Spencer, Andrew (2016). Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry. Bmc Medical Research Methodology, 16 (1) 151, 151. doi: 10.1186/s12874-016-0250-z |
|
2016 Journal Article Cardiac amyloid imaging with 18F-florbetaben PET: a pilot studyLaw, W. Phillip, Wang, William Y. S., Moore, Peter T., Mollee, Peter N. and Ng, Arnold C. T. (2016). Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study. Journal of Nuclear Medicine, 57 (11), 1733-1739. doi: 10.2967/jnumed.115.169870 |
|
2016 Journal Article The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experienceMoore, Peter T., Burrage, Matthew K., Mackenzie, Emily, Law, W. Philip, Korczyk, Dariusz and Mollee, Peter (2016). The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience. Heart, Lung and Circulation, 26 (11), 1183-1190. doi: 10.1016/j.hlc.2016.12.017 |
|
2016 Journal Article Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometryMollee, Peter, Boros, Samuel, Loo, Dorothy, Ruelcke, Jayde E., Lakis, Vanessa A., Cao, Kim‑Anh Lê, Renaut, Patricia and Hill, Michelle M. (2016). Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry. Clinical Proteomics, 13 (1) 30, 1-6. doi: 10.1186/s12014-016-9133-x |
|
2016 Journal Article Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patientsBurgess, M., Mapp, S., Mazzieri, R., Cheung, C., Cahmbers, L., Mattarollo, S., Mollee, P., Gill, D. and Saunders, N. A. (2016). Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients. Oncogene, 36 (17), 2366-2376. doi: 10.1038/onc.2016.387 |
|
2016 Journal Article Rapid molecular profiling of myeloproliferative neoplasms using targeted Exon Resequencing of 86 genes involved in JAK-STAT signaling and epigenetic regulationMagor, Graham W., Tallack, Michael R., Klose, Nathan M., Taylor, Debra, Korbie, Darren, Mollee, Peter, Trau, Matt and Perkins, Andrew C. (2016). Rapid molecular profiling of myeloproliferative neoplasms using targeted Exon Resequencing of 86 genes involved in JAK-STAT signaling and epigenetic regulation. Journal of Molecular Diagnostics, 18 (5), 707-718. doi: 10.1016/j.jmoldx.2016.05.006 |
|
2016 Journal Article Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversiesTate, Jillian R., Graziani, Maria Stella, Mollee, Peter and Merlini, Giampaolo (2016). Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies. Clinical Chemistry and Laboratory Medicine, 54 (6), 899-905. doi: 10.1515/cclm-2016-0268 |
|
2016 Journal Article Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosisMollee, Peter and Merlini, Giampaolo (2016). Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis. Clinical Chemistry and Laboratory Medicine, 54 (6), 921-927. doi: 10.1515/cclm-2015-0938 |
|
2016 Journal Article Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysisKennard, Alice, Hawley, Carmel, Tate, Jill, Klingberg, Sandra, Pretorius, Carel, Hutchison, Colin and Mollee, Peter (2016). Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis. Clinical Chemistry and Laboratory Medicine, 54 (6), 1045-1052. doi: 10.1515/cclm-2015-0799 |
|
2016 Journal Article Transcriptomic analysis of monocytes and macrophages derived from CLL patients which display differing abilities to respond to therapeutic antibody immune complexesBurgess, M., Ellis, J. J., Mapp, S., Mollee, P., Mazzieri, R., Mattarollo, S. R., Gill, D. and Saunders, N. A. (2016). Transcriptomic analysis of monocytes and macrophages derived from CLL patients which display differing abilities to respond to therapeutic antibody immune complexes. Genomics Data, 7, 4-6. doi: 10.1016/j.gdata.2015.11.010 |
|
2015 Journal Article Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: An Australian retrospective analysisMillar, A., Ellis, M., Mollee, P., Cochrane, T., Fletcher, J., Caudron, A., Webster, B. and Trotman, J. (2015). Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: An Australian retrospective analysis. Internal Medicine Journal, 45 (11), 1147-1153. doi: 10.1111/imj.12889 |
|
2015 Journal Article Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patientsTaylor, Emma, Jones, Mark, Hourigan, Matthew J., Johnson, David W., Gill, Devinder S., Isbel, Nicole, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher K., Campbell, Scott B. and Mollee, Peter (2015). Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients. Nephrology Dialysis Transplantation, 30 (10), 1774-1779. doi: 10.1093/ndt/gfv260 |
|
2015 Journal Article Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupWeber, N., Mollee, P., Augustson, B., Brown, R., Catley, L., Gibson, J., Harrison, S., Ho, P. J., Horvath, N., Jaksic, W., Joshua, D., Quach, H., Roberts, A. W., Spencer, A., Szer, J., Talaulikar, D., To, B., Zannettino, A. and Prince, H. M. (2015). Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (4), 371-382. doi: 10.1111/imj.12566 |
|
2015 Journal Article International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with cd20-positive b cell ptld: Clues from the ptld-1 trialTrappe, R. U., Choquet, S., Dierickx, D., Mollee, P., Zaucha, J. M., Dreyling, M. H., Duehrsen, U., Tarella, C., Shpilberg, O., Sender, M., Salles, G., Morschhauser, F., Jaccard, A., Lamy, T., Reinke, P., Neuhaus, R., Lehmkuhl, H., Horst, H. A., Leithaeuser, M., Schlattmann, P., Anagnostopoulos, I., Raphael, M., Riess, H., Leblond, V. and Oertel, S. (2015). International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with cd20-positive b cell ptld: Clues from the ptld-1 trial. American Journal of Transplantation, 15 (4), 1091-1100. doi: 10.1111/ajt.13086 |
|
2015 Journal Article Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupQuach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S., Mollee, P., Roberts, A. W., Horvath, N., Talaulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibson, J. and Prince, H. M. (2015). Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (3), 335-343. doi: 10.1111/imj.12688 |
